Table 1.
Onchocerciasis | Lymphatic filariasis | Intestinal helminths/schistosomiasis | Measles | Trachoma | |
---|---|---|---|---|---|
Objective | To establish within 12 years, effective and self sustainable community based ivermectin treatment throughout endemic areas in Africa | Elimination of lymphatic filariasis as public health problem by 2020 | Reduce morbidity and mortality; target school aged children through regular treatment | Global eradication | Elimination of blindness due to trachoma |
Programme strategy or intervention | Community directed treatment with ivermectin | Annual drug treatment with diethylcarbamazine plus albendazole or albendazole plus ivermectin in areas co-endemic for onchocerciasis. Vector control where appropriate | Mass chemotherapy through community treatment and school health programmes, improve sanitation, health education | High vaccination coverage of susceptible people: Catch up campaigns Follow up campaigns Surveillance | SAFE strategy (surgery, antibiotics, face washing, and environmental improvement—clean water and sanitation) |
Affected regions | 19 countries in WHO's AFRO region | ≥80 endemic countries in the tropics | All developing countries in tropics and subtropics; schistosomiasis particularly in Africa, South East Asia, and parts of the Americas | All except Americas | Global tropics |
Further examples are available on bmj.com